Palantir Stock Leads 3 High Growth Picks With Strong Balance Sheets

Healthy growth is hard to find when global data is so mixed, with some regions picking up speed and others cooling. A focused screener that looks for companies where analysts expect strong earnings growth over the next 3 years, while also checking that balance sheets are in acceptable shape, can help you cut through the noise. The Healthy high growth potential screener does exactly that. In this article you will see 3 stocks from this universe that stand out on growth quality and financial robustness, so you can decide whether any deserve a place on your watchlist.

Lemonade (LMND)

Overview: Lemonade is an insurance company that sells renters, homeowners, car, pet, life and landlord policies, mainly through a fully digital platform in the United States, Europe, Louisiana and the United Kingdom. It also acts as an agent for other insurers and covers stolen or damaged property and personal liability for accidents or damage to other people or their property.

Operations: Lemonade generates all of its US$975 million in revenue from property and casualty insurance, currently entirely from customers in the United States.

Market Cap: US$4.19b

Lemonade is attracting attention because it combines rapid top line expansion with a clear effort to tighten its underwriting and cost base. Recent results showed strong revenue and in force premium growth, a record low 5% loss adjustment expense ratio and a sharp reduction in adjusted EBITDA losses. This supports the view that its AI driven insurance model can scale more efficiently over time. At the same time, the stock carries real risks, including a rich P/S multiple versus traditional insurers, ongoing net losses and higher exposure to claims volatility as it keeps more risk on its own balance sheet. To understand how these positives and pressures could shape the next phase for Lemonade, investors may need to look beyond the headline growth story.

Lemonade’s fast scaling and AI focus are impressive, but the real question is how that story lines up against its current price. The DCF valuation analysis for Lemonade hints at where optimism could meet a hard limit.

Alignment Healthcare (ALHC)

Overview: Alignment Healthcare runs a consumer-focused healthcare platform that offers Medicare Advantage plans tailored to seniors across the United States, aiming to coordinate benefits, care delivery and support services under one roof. The company uses technology and data to try to improve outcomes while making it easier for older adults to manage their health coverage.

Operations: Alignment Healthcare generates about US$4.6b in revenue from providing healthcare services to members in the United States.

Market Cap: US$2.80b

Alignment Healthcare gives you exposure to a Medicare Advantage specialist that is already profitable and reporting membership and revenue growth, while leaning heavily on automation and real time data to control medical costs. The company recently raised 2026 revenue guidance and is investing in AI driven care management, clinical staff and new markets. These investments could support higher margins over time if they are successful. At the same time, you need to weigh valuation, funding entirely through external borrowing, legal noise around whistleblower allegations and ongoing regulatory disputes over star ratings and reimbursement. The key question is whether Alignment’s membership trends and technology heavy model can overcome these pressures and justify the optimism reflected in the stock.

Alignment Healthcare’s growth story and raised 2026 revenue guidance are only half the picture. The real question is whether the current price fully reflects the risks buried in the 3 key rewards and 1 important warning sign

Palantir Technologies (PLTR)

Overview: Palantir Technologies builds software platforms that help governments and companies bring together vast amounts of data, make sense of it and act on it, from counterterrorism and defense work to commercial analytics and AI driven decision making.

Market Cap: US$390.88b

Palantir Technologies sits at the center of two themes: defense grade data platforms and enterprise AI, with high profit margins and a strong balance sheet that includes zero debt and substantial cash. Recent results highlight very fast revenue growth, including almost doubling total revenue and rapid expansion in US commercial and government contracts. Return on equity sits above 30%, and earnings growth in the latest year far outpaced its 5 year average. The trade off is a very rich valuation and questions about how long hypergrowth and contract wins can keep up with expectations. For investors weighing that tension between quality and price, Palantir’s AI platforms and role in government programs raise questions that the headline numbers do not fully answer.

Palantir Technologies may appear to be driven purely by momentum, yet the real story lies at the intersection of defense-grade data, AI contracts, and a rich valuation. Get the full context inside the analysis report for Palantir Technologies

The three stocks in this article are just a starting point. The full Healthy high growth potential screener surfaces 265 more companies that analysts expect to grow earnings strongly while still meeting financial health checks, all captured inside the Healthy high growth potential screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter to you, so you can focus on the highest conviction opportunities for your watchlist.

Take Control of Your Investment Journey

If Palantir Technologies or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Momentum Shifts

Some of the most interesting stocks can move from quiet to breakout while everyone is still focused on yesterday’s winners. Before the next wave starts flying, consider getting in earlier in the cycle.

• Spot companies wiring the future of clean power infrastructure with the carefully filtered 36 power grid technology and infrastructure stocks. Do not wait until the grid upgrade story is already reflected in valuations.
• Review cash generative AI leaders using the curated 67 profitable AI stocks that aren't just burning cash. These are businesses already funding operations from real profits, not just relying on external capital.
• Explore the potential resurgence in nuclear build outs through the focused 89 nuclear energy infrastructure stocks. These stocks may react when sentiment changes, so it can be useful to research them while interest is still muted.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com